Home/Investors/Serum Institute of India

Serum Institute of India

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$616.9B

Focus Areas

7

Top Stage

Commercial

Investment Focus

Diabetes Oncology Immunology Autoimmune Diseases Nephrology Infectious Disease Respiratory Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Biocon	Commercial	$615.3B	Diabetes, Oncology
Novavax	Commercial	$1.6B	Infectious Disease, Respiratory Diseases

Frequent Co-Investors

Public shareholders via NSE listing1 shared Sanofi1 shared Coalition for Epidemic Preparedness Innovations (CEPI)1 shared U.S. Government (via Operation Warp Speed)1 shared